Patents by Inventor Zhongxiong Tang

Zhongxiong Tang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8101379
    Abstract: Provided is an anticoagulant fusion protein comprising oligopeptide recognizable and cleavable by either factor XIa and factor Xa or thrombin and factor Xa. Also provided are the preparation method of the anticoagulant fusion protein and medicinal use thereof.
    Type: Grant
    Filed: December 11, 2007
    Date of Patent: January 24, 2012
    Assignees: Institute of Radiation Medicine Academy of Military Medical Science, Beijing Sanly Sci-Tech Develop Inc. Ltd.
    Inventors: Zuze Wu, Aiping Yu, Chuanling Zhang, Zhongxiong Tang
  • Patent number: 8039513
    Abstract: The present invention relates to cis-1,2-substituted stilbene derivatives, or their pharmaceutically acceptable salts, glucosides or solvates, a pharmaceutical composition comprising the compound, and use of said compound for preparation of a drug for treatment and/or prevention of diabetes or improvement of diabetic complications.
    Type: Grant
    Filed: July 20, 2005
    Date of Patent: October 18, 2011
    Assignee: Institute of Radiation Medicine, Academy of Military Medical Sciences, PLA
    Inventors: Zhiyun Kang, Zuze Wu, Zhuangrong Sun, Zhongxiong Tang
  • Publication number: 20100234291
    Abstract: Provided is an anticoagulant fusion protein comprising oligopeptide recognizable and cleavable by either factor XIa and factor Xa or thrombin and factor Xa. Also provided are the preparation method of the anticoagulant fusion protein and medicinal use thereof.
    Type: Application
    Filed: December 22, 2009
    Publication date: September 16, 2010
    Applicants: INSTITUTE OF RADIATION MEDICINE, ACADEMY OF MILITARY MEDICAL SCIENCES, PLA, Beijing Sanly Sci-Tech Develop Inc. Ltd.
    Inventors: Zuze Wu, Aiping Yu, Chuanling Zhang, Zhongxiong Tang
  • Publication number: 20100113345
    Abstract: Provided is an anticoagulant fusion protein comprising oligopeptide recognizable and cleavable by either factor XIa and factor Xa or thrombin and factor Xa. Also provided are the preparation method of the anticoagulant fusion protein and medicinal use thereof.
    Type: Application
    Filed: December 11, 2007
    Publication date: May 6, 2010
    Applicant: BEIJING SANLY SCI-TECH DEVELOP INC. LTD.
    Inventors: Zuze Wu, Aiping Yu, Chuanling Zhang, Zhongxiong Tang
  • Publication number: 20090076114
    Abstract: The present invention relates to cis-1,2-substituted stilbene derivatives, or their pharmaceutically acceptable salts, glucosides or solvates, a pharmaceutical composition comprising the compound, and use of said compound for preparation of a drug for treatment and/or prevention of diabetes or improvement of diabetic complications.
    Type: Application
    Filed: July 20, 2005
    Publication date: March 19, 2009
    Inventors: Zhiyun Kang, Zuze Wu, Zhuangrong Sun, Zhongxiong Tang
  • Patent number: 7384920
    Abstract: This invention relates to a new use of stilbene derivatives or pharmaceutically acceptable salts thereof, especially in the manufacture of medicament for the prevention and treatment of diabetes or retrovirus associated diseases.
    Type: Grant
    Filed: July 26, 2001
    Date of Patent: June 10, 2008
    Assignees: Institute of Radiation Medicine, Academy of Military Medical Sciences, PLA, Beijing Luyin Lihua Pharmaceutical Science and Technology Development Company Ltd
    Inventors: Junlin Li, Zuze Wu, Lizhen Yuan, Qiang Li, Zhongxiong Tang
  • Publication number: 20050020511
    Abstract: This invention relates to a new use of stilbene derivatives or pharmaceutically acceptable salts thereof, especially in the manufacture of medicament for the prevention and treatment of diabetes or retrovirus associated diseases.
    Type: Application
    Filed: July 26, 2001
    Publication date: January 27, 2005
    Inventors: Junlin Li, Zuze Wu, Lizhen Yuan, Qiang Li, Zhongxiong Tang